DOC
Get informed when a big investor buys or sells
+ FollowUndervalued by 71.1% based on the discounted cash flow analysis.
| Market cap | $13.20 Billion |
|---|---|
| Enterprise Value | $23.75 Billion |
| Dividend Yield | $1.22 (6.37%) |
| Earnings per Share | $0.1 |
| Beta | 0.98 |
| Outstanding Shares | 695,161,000 |
| P/E Ratio | 59.92 |
|---|---|
| PEG | 17.02 |
| Price to Sales | 4.77 |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | 7.56 |
| Enterprise Value to EBIT | 33.7 |
| Enterprise Value to Net Income | 106 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 1.5 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2011▼ 138.17% |
|---|---|
| Total Calls | 3,381,100▲ 298.57% |
| Total Puts | 680,000▼ 49.36% |
Holdings and activity of institutional investors.
| Ownership % | 98.16%▲ 2.67% |
|---|---|
| Total Invested | $11.23B▲ 5.02% |
| Investors Holding | 769▼ 8.00% |
No data
As the primary committee for taxation, trade, and entitlement spending, it directly impacts corporate tax policy (crucial for REITs) and healthcare funding (Medicare pricing), which are fundamental to Healthpeak's revenue, tenant profitability, and overall valuation.
This committee allocates discretionary federal spending, including for healthcare programs. Its decisions directly impact the funding for hospitals, research institutions, and other healthcare providers that are Healthpeak's tenants, thus affecting their financial health and demand for properties.
This committee's jurisdiction over the FDA and NIH directly impacts the pharmaceutical and biotech sectors, which are key tenants for Healthpeak's life science properties. Labor laws also affect healthcare providers, influencing their ability to operate and pay rent.
This committee directly regulates the financial system (Fed, SEC) and real estate markets, both of which are central to Healthpeak's operations as a REIT. Regulatory changes or monetary policy decisions would have a direct, material impact.